Search

Dr. Sharon Ayd Joins Reglagene Board of Directors

Updated: Feb 27, 2020

Reglagene is delighted to add Sharon Ayd, PhD, MBA to its Board of Directors. In Dr. Ayd’s 30-year career, she has gained experience commercializing pharmaceuticals from discovery to clinical evaluation, expanded core businesses, and transformed pharmaceutical business operations. Her career began as a research scientist for Baxter International. She went on to serve in a variety of executive positions at companies including Apotex Inc., Hospira (now Pfizer), Fresenius-Kabi, Transcend Therapeutics, Advanced Life Sciences, and Pinnacle Biologics. Dr. Ayd is an industry expert in regulatory strategy and pharmaceutical operations. She has led the regulatory affairs activity for many due diligence projects, resulting in product licensing, mergers and acquisitions, and divestitures. Under her leadership, ~100 drug application approvals (original and supplements) have been obtained. Dr. Ayd holds an MBA from Lewis University and a PhD from the University of Illinois at Chicago in Biopharmaceutical Sciences, and she is an alumnus of Women In Bio’s inaugural class in its Boardroom Ready program, a foundational resource to prepare executive women for service on corporate boards.


Recent Posts

See All

Reglagene Featured on KGUN News!

"That's what we want to do. That is the dream: to irreversibly cure people's cancer," said Richard Austin, the CEO and Co-Founder of Reglagene. Reglagene was featured on KGUN news today!

Reglagene Featured in the Arizona Daily Star!

Reglagene was featured in the Arizona Daily Star! Director of Biology Teri Suzuki and Business Development Manager Michael Abrahamson were interviewed. Click here to read the full article and intervie

OFFICE

1703 E Mabel St
Tucson, AZ 85721
USA

www.reglagene.com  |  https://www.linkedin.com/company/reglagene/ | ©2020 by Reglagene Holding, Inc.